Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.

Clinical colorectal cancer

Volumn 5, Issue 3, 2005, Pages 181-187

  Atkins, James N ^a   Jacobs, Samuel A ^a   Wieand, H Samuel ^a   Smith, Roy E ^a   John, William J ^a   Colangelo, Linda H ^a   Vogel, Victor G ^a   Kuebler, J Philip ^a   Cescon, Terrence P ^a   Miller, Barbara J ^a   Geyer Jr , Charles E ^a   Wolmark, Norman ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GLUTAMIC ACID DERIVATIVE; GUANINE; OXALIPLATIN; PEMETREXED; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; GLUTAMATES; GUANINE; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 32944481077     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2005.n.029     Document Type: Article

References (0)